Hongqiang Li

Hongqiang Li

Auto-generated profile, based on publicly available information

Hongqiang Li

Department of Thyroid Surgery Zhengzhou Henan China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2020 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
BSBingke Sun
Bingke Sun
SXShumin Xu
Shumin Xu
YYYanli Yan
Yanli Yan
YLYusheng Li
Yusheng Li
HLHongqiang Li
Hongqiang Li
JBJianwen Bai
Jianwen Bai
Objective: To investigate the role of miR-205 and GATA3 in Pulmonary Fibrosis (PF). Methods: Bleomycin (BLM) was used to induce PF in SD rats and in vitro PF model was established by using TGFβ1-induced RLE-6TN cells. miR-205 mimics were used for the overexpression of miR- 205. The expression of miR-205, GATA3, α-SMA, Collagen I, CHOP and GRP78 were measured using RT-qPCR or western blotting. Dual-luciferase reporter assay was used to confirm binding between GATA3 3’-UTR and miR-205. Results: The expression of miR-205 was significantly down-regulated, while the expression of GATA3 was remarkably up-regulated in the model rats. GATA3 levels were remarkably decreased when miR-205 was overexpressed. When miR-205 was overexpressed, the lung injury by BLM-induced fibrosis was improved. The expression of α-SMA, Collagen I, as well as GRP78 and CHOP, was significantly up-regulated in both in vivo and in vitro PF models, and overexpression of miR-205 remarkably reversed the effects. Dual-luciferase reporter assay showed that miR-205 directly targeted and negatively regulated GATA3. Conclusion: miR-205 improved pulmonary fibrosis through inhibiting ER-stress by targeting GATA3.

27 February 2024 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
HGHaohao Guo
Haohao Guo
ZWZiyang Wang
Ziyang Wang
KYKeyu Yin
Keyu Yin
RMRunsheng Ma
Runsheng Ma
YZYifei Zhang
Yifei Zhang
DYDetao Yin
Detao Yin